{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:34:05Z","timestamp":1794065645192,"version":"4.8.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jneuroim.2023.578243","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T16:35:12Z","timestamp":1699893312000},"page":"578243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"385","author":[{"given":"Alireza","family":"Soltani Khaboushan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysan","family":"Moeinafshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hamed","family":"Ersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Majidi Zolbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol-Mohammad","family":"Kajbafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578243_bb0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fnins.2019.01026","article-title":"Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients","volume":"13","author":"Bai","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578243_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1582-4934.2010.01011.x","article-title":"Early defect of transforming growth factor \u03b21 formation in Huntington\u2019s disease","volume":"15","author":"Battaglia","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ynstr.2018.05.003","article-title":"Chronic stress as a risk factor for Alzheimer\u2019s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress","volume":"9","author":"Bisht","year":"2018","journal-title":"Neurobiol. Stress."},{"issue":"8","key":"10.1016\/j.jneuroim.2023.578243_bb0020","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.jneuroim.2023.578243_bb0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2023.578243_bb0030","first-page":"A23","article-title":"F07 cross-sectional and longitudinal associations between CRP and neuropsychiatric symptoms in HD","volume":"83","author":"Bouwens","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.jneuroim.2023.578243_bb0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.euroneuro.2014.05.004","article-title":"Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington\u2019s disease","volume":"24","author":"Bouwens","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0040","series-title":"D4 Prediction of huntington\u2019s Disease Phenotype by Cerebrospinal Fluid Biomarkers of Inflammation and Cell Death","author":"Byrne","year":"2016"},{"key":"10.1016\/j.jneuroim.2023.578243_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0055","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2023.578243_bb0060","first-page":"A16","article-title":"A45 clusters of connected pathways through multisource data integration in huntingtons disease","volume":"89","author":"Christodoulou","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"17","key":"10.1016\/j.jneuroim.2023.578243_bb0065","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.3390\/ijms21176363","article-title":"Levels of interleukin-6 in saliva, but not plasma, correlate with clinical metrics in Huntington\u2019s disease patients and healthy control subjects","volume":"21","author":"Corey-Bloom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578243_bb0070","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578243_bb0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","article-title":"DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington\u2019s mice (R6\/2) reveals neuroinflammation and insulin associations","volume":"1088","author":"Crocker","year":"2006","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578243_bb0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington\u2019s disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578243_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0090","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0095","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578243_bb0100","first-page":"1520","article-title":"Natural history of Huntington disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0105","series-title":"Movement Disorders","article-title":"Changes in cerebral vasculature in patients with Huntington\u2019s disease","author":"Drouin-Ouellet","year":"2013"},{"key":"10.1016\/j.jneuroim.2023.578243_bb0110","doi-asserted-by":"crossref","first-page":"603594","DOI":"10.3389\/fimmu.2020.603594","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease","volume":"11","author":"Du","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603594","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease","volume":"11","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4939-1071-7_5","article-title":"Oxidative stress, neuroinflammation, and neurodegeneration","author":"Gao","year":"2014","journal-title":"Neuroinflamm. Neurodegen."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578243_bb0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-981-13-9913-8_14","article-title":"Astrocytes in Huntington\u2019s disease","volume":"1175","author":"Gray","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578243_bb0140","article-title":"Huntington\u2019disease\u2013imbalance of amino acid levels in plasma of patients and mutation carriers","volume":"20","author":"Gruber","year":"2013","journal-title":"Ann. Agric. Environ. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2023.578243_bb0145","first-page":"A54","article-title":"Q01 SIRT 1 mediated modulation of circulating cytokines in huntington\u2019s disease-pharmacodynamics results from phase 1B study of selisistat\u2014a SIRT 1 inhibitor","volume":"83","author":"Haider","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2023.578243_bb0150","series-title":"Doing Meta-Analysis in R","author":"Harrer","year":"2019"},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578243_bb0155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and toxic neuroinflammation in amyotrophic lateral sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurotherap. J. Am. Soc. Exp. NeuroTherap."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"issue":"37","key":"10.1016\/j.jneuroim.2023.578243_bb0165","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.jneuroim.2023.578243_bb0170","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms22168363","article-title":"New avenues for the treatment of Huntington\u2019s disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578243_bb0175","doi-asserted-by":"crossref","first-page":"621.e17-33","DOI":"10.1016\/j.neurobiolaging.2011.02.015","article-title":"Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons","volume":"33","author":"Kraft","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578243_bb0180","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI64484","article-title":"Mutant huntingtin impairs immune cell migration in Huntington disease","volume":"122","author":"Kwan","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0185","series-title":"Activated Immune System in Patients with Huntington\u2019s Disease","author":"Leblhuber","year":"1998"},{"issue":"10","key":"10.1016\/j.jneuroim.2023.578243_bb0190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated immune system in patients with Huntington\u2019s disease","volume":"36","author":"Leblhuber","year":"1998","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578243_bb0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578243_bb0200","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"issue":"22","key":"10.1016\/j.jneuroim.2023.578243_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578243_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2023.578243_bb0220","doi-asserted-by":"crossref","first-page":"147444","DOI":"10.1016\/j.brainres.2021.147444","article-title":"Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease","volume":"1762","author":"Moghaddam","year":"2021","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578243_bb0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/jnc.14674","article-title":"Inflammatory mechanisms in neurodegeneration","volume":"149","author":"Nichols","year":"2019","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.jneuroim.2023.578243_bb0230","article-title":"Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis","volume":"9","author":"Obrador","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"6733","key":"10.1016\/j.jneuroim.2023.578243_bb0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature."},{"issue":"8","key":"10.1016\/j.jneuroim.2023.578243_bb0240","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.jneuroim.2023.578243_bb0245","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0250","series-title":"D11 Plasma Brain-Derived Neurotrophic Factor Level as Huntington Disease Severity Biomarker","author":"Plinta","year":"2018"},{"issue":"13","key":"10.1016\/j.jneuroim.2023.578243_bb0255","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3390\/jcm10133001","article-title":"Is TGF-\u03b21 a biomarker of Huntington\u2019s disease progression?","volume":"10","author":"Plinta","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578243_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041561","article-title":"What, when and how to measure-peripheral biomarkers in therapy of Huntington\u2019s disease","volume":"22","author":"Przybyl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578243_bb0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","article-title":"A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease","volume":"9","author":"Qu","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578243_bb0280","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000984","article-title":"Microglia activation in basal ganglia is a late event in Huntington disease pathophysiology","volume":"8","author":"Rocha","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578243_bb0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/WNN.0000000000000301","article-title":"Clinical correlates of depression and suicidality in Huntington disease: An analysis of the enroll-HD observational study","volume":"35","author":"Rocha","year":"2022","journal-title":"Cogn. Behav. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2023.578243_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163479","article-title":"Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s disease","volume":"11","author":"Rodrigues","year":"2016","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0295","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578243_bb0300","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","article-title":"Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia","volume":"20","author":"Saba","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0305","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","article-title":"Oxidative stress and inflammation biomarkers in the blood of patients with Huntington\u2019s disease","volume":"34","author":"S\u00e1nchez-L\u00f3pez","year":"2012","journal-title":"Neurol. Res."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578243_bb0310","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","article-title":"Oxidative stress and inflammation biomarkers in the blood of patients with Huntington\u2019s disease","volume":"34","author":"S\u00e1nchez-L\u00f3pez","year":"2012","journal-title":"Neurol. Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578243_bb0315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0320","series-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578243_bb0325","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res. Synth. Methods"},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578243_bb0330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JHD-170273","article-title":"A critical evaluation of wet biomarkers for Huntington\u2019s disease: current status and ways forward","volume":"7","author":"Silajd\u017ei\u0107","year":"2018","journal-title":"J. Huntington\u2019s Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578243_bb0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JHD-130049","article-title":"A critical evaluation of inflammatory markers in Huntington\u2019s disease plasma","volume":"2","author":"Silajd\u017ei\u0107","year":"2013","journal-title":"J. Huntington\u2019s Dis."},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578243_bb0340","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00114","article-title":"Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases","volume":"12","author":"Solleiro-Villavicencio","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.jneuroim.2023.578243_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273920","article-title":"Cytokines and chemokines profile in encephalitis patients: a meta-analysis","volume":"17","author":"Soltani Khaboushan","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.jneuroim.2023.578243_bb0355","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578243_bb0360","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.jneuroim.2023.578243_bb0365","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3390\/molecules23123167","article-title":"Characterization of endocannabinoid-metabolizing enzymes in human peripheral blood mononuclear cells under inflammatory conditions","volume":"23","author":"Szafran","year":"2018","journal-title":"Molecules."},{"issue":"Pt 7","key":"10.1016\/j.jneuroim.2023.578243_bb0370","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578243_bb0375","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/s1980-5764-2016dn1004002","article-title":"Revisiting the neuropsychiatry of Huntington\u2019s disease","volume":"10","author":"Teixeira","year":"2016","journal-title":"Dement. Neuropsychol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116653","article-title":"Inflammatory changes in peripheral organs in the BACHD murine model of Huntington\u2019s disease","volume":"232","author":"Valad\u00e3o","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in Huntington\u2019s disease: a few new twists on an old tale","volume":"348","author":"Valad\u00e3o","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0390","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2016.02.012","article-title":"Revelation of the IFN\u03b1, IL-10, IL-8 and IL-1\u03b2 as promising biomarkers reflecting immuno-pathological mechanisms in porcine Huntington\u2019s disease model","volume":"293","author":"Valekova","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.jneuroim.2023.578243_bb0395","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578243_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578243_bb0405","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000287","article-title":"Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease","volume":"3","author":"Vinther-Jensen","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0410","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","article-title":"Neuropathology of Huntington\u2019s disease","volume":"89","author":"Vonsattel","year":"2008","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578243_bb0415","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0420","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2023.578243_bb0425","series-title":"Tryptophan, Serotonin, and Melatonin: Basic Aspects and Applications","first-page":"133","article-title":"Degradation of tryptophan in neurodegenerative disorders","author":"Widner","year":"1999"},{"key":"10.1016\/j.jneuroim.2023.578243_bb0430","first-page":"3","article-title":"Abnormal peripheral chemokine profile in Huntington\u2019s disease","author":"Wild","year":"2011","journal-title":"PLoS Curr."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823002291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:58:12Z","timestamp":1736366292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":86,"alternative-id":["S0165572823002291"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578243","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578243"}}